Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1316-1321

  Yoon, Myeong Ho ^a   Reriani, Martin ^a   Mario, Gössl ^a   Rihal, Charanjit ^a   Gulati, Rajiv ^a   Lennon, Ryan ^a   Tilford, Jonella M ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Endothelial function; Endothelin receptor (ETA) antagonist; Intravascular ultrasound (IVUS); Normalized mean total atheroma volume (TAVMEAN); Percent atheroma volume (PAV)

Indexed keywords

ATRASENTAN; PLACEBO; STATIN (PROTEIN);

ADULT; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; EPICARDIUM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ENDOTHELIAL FUNCTION; ENDOTHELIN RECEPTOR (ET(A)) ANTAGONIST; INTRAVASCULAR ULTRASOUND (IVUS); NORMALIZED MEAN TOTAL ATHEROMA VOLUME (TAV(MEAN)); PERCENT ATHEROMA VOLUME (PAV);

ADULT; ATHEROSCLEROSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; TIME FACTORS;

EID: 84885325414     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.001     Document Type: Article

References (37)

1. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-75.
2. Hasdai D, Gibbons RJ, Holmes Jr DR, et al. Coronary endothelial dysfunction In humans Is associated with myocardial perfusion defects. Circulation 1997;96: 3390-5.
3. Zeiher AM, Krause T, Schachinger V, et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels Is associated with exercise-induced myocardial Ischemia. Circulation 1995;91:2345-52.
4. Lavi S, Bae JH, Rihal CS, et al. Segmental coronary endothelial dysfunction In patients with minimal atherosclerosis Is associated with necrotic core plaques. Heart 2009;95:1525-30.
5. Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101: 948-54.
6. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-8.
7. Lerman A, Edwards BS, Hallett JW, et al. Circulating and tissue endothelin Immunoreactivity In advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
8. Lerman A, Holmes Jr DR, Bell MR, et al. Endothelin In coronary endothelial dysfunction and early atherosclerosis In humans. Circulation 1995;92:2426-31.
9. Best PJ, McKenna CJ, Hasdai D, et al. Chronic endothelin receptor antagonism preserves coronary endothelial function In experimental hypercholesterolemia. Circulation 1999;99:1747-52.
10. Hasdai D, Lerman A. The atherogenic potential of endothelin. Coron Artery Dis 1995;6:901-4.
11. Kowala MC, Rose PM, Stein PD, et al. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis In hamsters fed cholesterol. Am J Pathol 1995;146:819-26.
12. Reriani M, Raichlin E, Prasad A, et al. Long-term administration of endothelin receptor antagonist Improves coronary endothelial function In patients with early atherosclerosis. Circulation 2010;122:958-66.
13. Raichlin E, Prasad A, Mathew V, et al. Efficacy and safety of Atrasentan In patients with cardiovascular risk and early atherosclerosis. Hypertension 2008;52:522-8.
14. Crow RS, Prineas RJ, Jacobs Jr DR, et al. A new epidemiologic classification system for Interim myocardial Infarction from serial electrocardiographic changes unstable angina. A classification. Am J Cardiol 1989;64:454-61.
15. Braunwald E. Unstable angina. A classification. Circulation 1989;80:410-4.
16. Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for Intravascular measurement of coronary artery flow velocity. Circulation 1992;85: 1899-911.
17. Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics In normal and diseased arteries. Am J Cardiol 1993;71:3D-9D.
18. Quyyumi AA, Dakak N, Andrews NP, et al. Contribution of nitric oxide to metabolic coronary vasodilation In the human heart. Circulation 1995;92:320-6.
19. Al Suwaidi J, Higano ST, Holmes Jr DR, et al. Measuring maximal percent area stenosis poststent placement with Intracoronary Doppler and the continuity equation and correlation with Intracoronary ultrasound and angiography. Am J Cardiol 1999;84:650-4.
20. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (iVUS). A report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol 2001;37:1478-92.
21. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
22. Crauwels HM, Van Hove CE, Holvoet P, et al. Plaque-associated endothelial dysfunction In apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein Ai. Cardiovasc Res 2003;59:189-99.
23. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-35.
24. Reriani MK, Lerman LO, Lerman A. Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med 2010;4:351-60.
25. Anderson TJ. Assessment and treatment of endothelial dysfunction In humans. J Am Coll Cardiol 1999;34:631-8.
26. Halcox JP,Nour KR, Zalos G, Quyyumi AA. Coronary vasodilation and Improvement In endothelial dysfunction with endothelin ET(A) receptor blockade. Circ Res 2001;89: 969-76.
27. MacCarthy PA, Pegge NC, Prendergast BD, et al. The Physiological role of endogenous endothelin In the regulation of human coronary vasomotor tone. J Am Coll Cardiol 2001;37:137-43.
28. Kyriakides ZS, Kremastinos DT, Bofilis E, et al. Endogenous endothelin maIntains coronary artery tone by endothelin type A receptor stimulation In patients undergoing coronary arteriography. Heart 2000;84:176-82.
29. Li JS, Lariviere R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling In deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin In vascular hypertrophy. Hypertension 1994;24: 183-8.
30. Dashwood MR, Barker SG, Muddle JR, et al. [125i]-endothelin-1 binding to vasa vasorum and regions of neovascularization In human and porcine blood vessels: a possible role for endothelin In Intimal hyperplasia and atherosclerosis. J Cardiovasc Pharmacol 1993;22(Suppl. 8):S343-7.
31. Mathew V, Hasdai D, Lerman A. The role of endothelin In coronary atherosclerosis. Mayo Clin Proc 1996;71:769-77.
32. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to Inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 In clinically healthy smokers. Circulation 1994;90:27-34.
33. Mencarelli M, Pecorelli A, Carbotti P, et al. Endothelin receptor A expression In human Inflammatory cells. Regul Pept 2009;158:1-5.
34. Lin CY, Lee TS, Chen CC, et al. Endothelin-1 exacerbates lipid accumulation by Increasing the protein degradation of the ATP-binding cassette transporter G1 In macrophages. J Cell Physiol 2011;226(8):2198-205.
35. Babaei S, Picard P, Ravandi A, et al. Blockade of endothelin receptors markedly reduces atherosclerosis In LDL receptor deficient mice: role of endothelin In macrophage foam cell formation. Cardiovasc Res 2000;48:158-67.
36. Browatzki M, Pfeiffer CA, Schmidt J, Kranzhofer R. Endothelin-1 Induces CD40 but not IL-6 In human monocytes via the proinflammatory transcription factor NF-kappaB. Eur J Med Res 2005;10:197-201.
37. Morand-ContantM, Anand-SrivastavaMB, Couture R. Kinin B1 receptor upregulation by angiotensin II and endothelin-1 In rat vascular smoothmuscle cells: receptors and mechanisms. Am J Physiol Heart Circ Physiol 2010;299:H1625-32.